Display options
Cite
Planes A, Vochelle N, Ferru J, et al. Enoxaparine low molecular weight heparin: its use in the prevention of deep venous thrombosis following total hip replacement. Haemostasis. 1986;16(2):152-8doi: 10.1159/000215285.
Planes, A., Vochelle, N., Ferru, J., Przyrowski, D., Clerc, J., Fagola, M., & Planes, M. (1986). Enoxaparine low molecular weight heparin: its use in the prevention of deep venous thrombosis following total hip replacement. Haemostasis, 16(2), 152-8. https://doi.org/10.1159/000215285
Planes, A, et al. "Enoxaparine low molecular weight heparin: its use in the prevention of deep venous thrombosis following total hip replacement." Haemostasis vol. 16,2 (1986): 152-8. doi: https://doi.org/10.1159/000215285
Planes A, Vochelle N, Ferru J, Przyrowski D, Clerc J, Fagola M, Planes M. Enoxaparine low molecular weight heparin: its use in the prevention of deep venous thrombosis following total hip replacement. Haemostasis. 1986;16(2):152-8. doi: 10.1159/000215285. PMID: 3710293.
Copy Download .nbib Format: NLM
Share it on

Haemostasis. 1986;16(2):152-8. doi: 10.1159/000215285.

Enoxaparine low molecular weight heparin: its use in the prevention of deep venous thrombosis following total hip replacement.

Haemostasis

A Planes, N Vochelle, J Ferru, D Przyrowski, J Clerc, M Fagola, M Planes

PMID: 3710293 DOI: 10.1159/000215285

Abstract

UNLABELLED: The effect of Enoxaparin in the prevention of thromboembolism after total hip prosthesis has been controlled by phlebography. 228 consecutives patients were studied with 4 dose regimens: 60 mg once a day, 40 mg once a day, and 30 and 20 mg twice a day.

CONCLUSIONS: a total dose of 40 mg once a day or twice a day gives a rate of postoperative thrombosis of 8%.

Cited by

Substances

MeSH terms

Publication Types

LinkOut - more resources